Fair Value Calculator Fair Value Calculator
EN DE

INFRONICS (INFRONICS) Fair Value & Analysis

IN · Market cap ₹141M

I INFRONICS INFRONICS · BSE
Price₹17.75
Fair Value₹3.00
Upside-83.1%
Quality49/100
Watch INFRONICS for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹1.98 – ₹3.75

Fair value as of: Jul 5, 2026

From 1 valuation models · updated today

Share price +0.9% over the past month.

Price vs Fair Value (12 months)

₹33.41 ₹13.36 Fair Value ₹3.00 Jul 2025 Jul 2026

12‑month range ₹13.36 – ₹33.41 · fair‑value band ₹1.98 – ₹3.75 · the ₹17.75 price screens above the ₹3.00 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

INFRONICS (INFRONICS) currently trades at ₹17.75, while our model-based Fair Value estimate is ₹3.00 — implying the stock looks roughly 83.1% overvalued today. We read business quality at 49/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at ₹6.5M. It earns a return on equity of -25.1%. Net debt stands at ₹4.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹1.98 (bear case) to ₹3.75 (bull case); at ₹17.75, the current price sits above that range. The share trades about 49% below its 52-week high and 37% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹6.5M
Revenue growth (YoY) -99.6%
Return on equity -25.1%
Free cash flow −₹5.5M FY2026
EPS (TTM) ₹-0.9400
EPS growth (YoY) -49.5%
More key figures
Net debt ₹4.1M FY2021

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

INFRONICS reported revenue of ₹0 in FY2026 versus ₹67.8M in FY2022. Reported net income was −₹7.5M in FY2026.

Revenue
FY22 ₹67.8M
FY23 ₹61.8M
FY24 ₹43.4M
FY25 ₹22.9M
FY26 ₹0
Net income
FY22 ₹483K
FY23 ₹5.2M
FY24 ₹25.2M
FY25 ₹11.2M
FY26 −₹7.5M

Is INFRONICS fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "INFRONICS Fair Value". https://www.fairvalue-calculator.com/stock/INFRONICS

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is INFRONICS (INFRONICS) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹3.00 versus a price of ₹17.75 — about −83% (overvalued). Model-based estimate, not financial advice.
What is the fair value of INFRONICS?
Our model-based fair value for INFRONICS is ₹3.00 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹17.75.
What is the quality score of INFRONICS?
INFRONICS has a Quality Score of 49/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of INFRONICS (INFRONICS)?
INFRONICS reported trailing-twelve-month revenue of about ₹6.5M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of INFRONICS?
The net profit margin of INFRONICS is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.